(S1 (S (NP (NP (NNP Gen-Probe) (NNP Inc.)) (, ,) (NP (DT a) (NN biotechnology) (NN concern)) (, ,)) (VP (VBD said) (SBAR (S (NP (PRP it)) (VP (VBD signed) (NP (DT a) (JJ definitive) (NN agreement) (S (VP (TO to) (VP (VB be) (VP (VBN acquired) (PP (IN by) (NP (NP (NNP Chugai) (NNP Pharmaceutical) (NNP Co.)) (PP (IN of) (NP (NNP Tokyo))))) (PP (IN for) (NP (NP (QP (RB about) ($ $) (CD 110) (CD million))) (, ,) (CC or) (ADVP (RB almost) (RB double)) (NP (NP (DT the) (NN market) (NN price)) (PP (IN of) (NP (NP (NNP Gen-Probe) (POS 's)) (NN stock))))))))))))))) (. .)))

(S1 (S (NP (DT The) (NN move)) (VP (VBZ is) (ADJP (JJ sure) (S (VP (TO to) (VP (VB heighten) (NP (NP (NNS concerns)) (PP (IN about) (NP (NP (VBN increased) (JJ Japanese) (NN investment)) (PP (IN in) (NP (NNP U.S.) (NN biotechnology) (NNS firms))))))))))) (. .)))

(S1 (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB bolster) (NP (NNS fears) (SBAR (IN that) (S (NP (DT the) (NNPS Japanese)) (VP (MD will) (VP (VB use) (NP (NP (PRP$ their) (NN foothold)) (PP (IN in) (NP (NNP U.S.) (NN biotechnology) (NNS concerns)))) (S (VP (TO to) (VP (VB gain) (NP (JJ certain) (NN trade) (CC and) (JJ competitive) (NNS advantages))))))))))))))) (. .)))

(S1 (S (NP (NP (NNP Gen-Probe)) (, ,) (NP (NP (DT an) (NN industry) (NN leader)) (PP (IN in) (NP (NP (DT the) (NN field)) (PP (IN of) (NP (JJ genetic) (NNS probes)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN technology)) (VP (VBN used) (PP (IN in) (NP (JJ diagnostic) (NNS tests)))))))) (, ,)) (NP (JJ last) (NN year)) (VP (VBD signed) (NP (DT an) (NN agreement) (SBAR (IN for) (S (NP (NNP Chugai)) (VP (TO to) (ADVP (RB exclusively)) (VP (VB market) (NP (PRP$ its) (JJ diagnostic) (NNS products)) (PP (IN in) (NP (NNP Japan))) (PP (IN for) (NP (NP (JJ infectious) (NNS diseases)) (CC and) (NP (NN cancer)))))))))) (. .)))

(S1 (S (NP (NNP Chugai)) (VP (VBD agreed) (S (RB then) (VP (TO to) (VP (VB fund) (NP (JJ certain) (JJ associated) (NN research) (CC and) (NN development) (NNS costs)))))) (. .)))

(S1 (S (S (NP (DT That) (NN arrangement)) (ADVP (RB apparently)) (VP (VBZ has) (VP (VBN worked) (ADVP (RB well))))) (, ,) (CC and) (S (NP (NP (NNP Thomas) (NNP A.) (NNP Bologna)) (, ,) (NP (NP (NP (NN president)) (CC and) (NP (JJ chief) (JJ executive) (NN officer))) (PP (IN of) (NP (NP (NNP Gen-Probe)) (, ,) (VP (VBN founded) (PP (IN in) (NP (CD 1983))))))) (, ,)) (VP (VBD said) (SBAR (S (NP (NP (DT the) (NN sale)) (PP (IN of) (NP (DT the) (NN company)))) (VP (VBZ means) (`` `) (S (`` `) (NP (PRP we)) (VP (MD will) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB concentrate) (PP (IN on) (S (VP (VP (VBG running) (NP (DT the) (NN business))) (CONJP (RB rather) (IN than)) (VP (ADVP (RB always)) (VBG looking) (PP (IN for) (NP (NP (NNS sources)) (PP (IN of) (NP (NN financing))))))))))))))))))))) (. .) ('' ') ('' ')))

(S1 (S (NP (NNP Chugai)) (VP (VBD agreed) (S (VP (TO to) (VP (VB pay) (NP (NP ($ $) (CD 6.25)) (NP (DT a) (NN share))) (PP (IN for) (NP (NP (NP (NNP Gen-Probe) (POS 's)) (QP (CD 17.6) (CD million)) (JJ common) (NNS shares)) (ADJP (JJ outstanding)))) (PP (IN on) (NP (DT a) (ADJP (RB fully) (VBN diluted)) (NN basis))))))) (. .)))

(S1 (S (NP (NN Yesterday)) (, ,) (PP (IN in) (NP (JJ national) (NN trading))) (PP (IN in) (NP (DT the) (JJ over-the-counter) (NN market))) (, ,) (NP (NNP Gen-Probe) (NN common)) (VP (VBD closed) (PP (IN at) (NP (NP ($ $) (CD 3.25)) (NP (DT a) (NN share))))) (. .)))

(S1 (S (SBAR (IN Because) (S (NP (DT the) (NNP U.S.)) (VP (VBZ leads) (PP (IN in) (NP (NP (JJS most) (NNS areas)) (PP (IN of) (NP (NN biotechnology)))))))) (PRN (: --) (PP (ADVP (RB largely)) (IN because) (IN of) (NP (NP (NN research) (NN investment)) (PP (IN by) (NP (DT the) (NNP U.S.) (NN government))))) (: --)) (NP (DT the) (NN sale)) (VP (VBZ is) (ADJP (JJ sure) (S (VP (TO to) (VP (VB increase) (NP (NNS concerns) (SBAR (IN that) (S (NP (JJ Japanese) (NNS companies)) (VP (MD will) (VP (VP (VB buy) (NP (NNP American) (NN know-how))) (CC and) (VP (VB use) (NP (PRP it)) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT the) (JJ upper) (NN hand)) (PP (IN in) (NP (NP (NN biotechnology) (NN trade)) (CC and) (NP (NN competition))))))))))))))))))) (. .)))

(S1 (SINV (`` `) (S (`` `) (NP (DT The) (NN biotechnology) (NNS firms)) (VP (MD may) (VP (VB be) (VP (VBG setting) (PRT (RP up)) (NP (PRP$ their) (JJ own) (NNS competitors)))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (NNP Richard) (NNP Godown)) (, ,) (NP (NP (NN president)) (PP (IN of) (NP (DT the) (NNP Industrial) (NNP Biotechnology) (NNP Association))))) (. .)))

(S1 (S (NP (PRP He)) (VP (VBD added) (SBAR (IN that) (S (PP (IN until) (ADVP (RB now))) (NP (DT the) (NNPS Japanese)) (VP (VBP have) (ADVP (RB only)) (VP (VBN acquired) (NP (NP (NN equity) (NNS positions)) (PP (IN in) (NP (NNP U.S.) (NN biotechnology) (NNS companies))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP They)) (VP (VBP are) (VP (VBG piggybacking) (PP (IN onto) (NP (JJ developed) (NN technology))))) (, ,) ('' ')) ('' ') (NP (PRP he)) (VP (VBD said)) (. .)))

(S1 (S (PP (IN During) (NP (DT the) (JJ past) (CD five) (NNS years))) (, ,) (NP (JJ Japanese) (NNS concerns)) (VP (VBP have) (VP (VBN invested) (PP (IN in) (NP (NP (JJ several)) (PP (IN of) (NP (NP (DT the) (NNP U.S.) (POS 's)) (CD 431) (JJ independent) (NN biotechnology) (NNS companies))))))) (. .)))

(S1 (S (S (NP (NNP Chugai)) (VP (VBZ has) (VP (VBN been) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ active)) (JJ Japanese) (NNS players)) (PP (IN in) (NP (NNP U.S.) (NN biotechnology) (NNS companies))))))))) (: ;) (S (NP (PRP it)) (VP (VBZ has) (NP (NP (NP (DT an) (NN equity) (NN investment)) (PP (IN in) (NP (NP (NNP Genetics) (NNP Institute) (NNP Inc.)) (, ,) (NP (NP (NNP Cambridge)) (, ,) (NP (NNP Mass.))) (, ,)))) (CC and) (NP (NP (DT a) (NN joint-venture) (NN agreement)) (PP (IN with) (NP (NP (NNP Upjohn) (NNP Co.)) (, ,) (NP (NP (NNP Kalamazoo)) (, ,) (NP (NNP Mich))))))))) (. .)))

(S1 (S (NP (DT The) (JJ Japanese) (NN government)) (PRN (, ,) (S (NP (NNP Mr.) (NNP Godown)) (VP (VBD said))) (, ,)) (VP (VBZ has) (VP (VBN stated) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ wants) (S (NP (NP (QP (CD 10) (NN %) (TO to) (CD 11) (NN %))) (PP (IN of) (NP (PRP$ its) (JJ gross) (JJ national) (NN product)))) (VP (TO to) (VP (VB come) (PP (IN from) (NP (NN biotechnology) (NNS products))))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP It)) (VP (VBZ is) (VP (VBG becoming) (NP (NP (JJR more)) (PP (IN of) (NP (NP (DT a) (NN horse) (NN race)) (NP (DT every) (NN day))))) (PP (IN between) (NP (NP (DT the) (NNP U.S.)) (CC and) (NP (NNP Japan)))))) (, ,) ('' ')) ('' ') (NP (PRP he)) (VP (VBD said) (, ,) (S (VP (VBG adding) (SBAR (IN that) (S (NP (DT some)) (VP (VBP fear) (SBAR (IN that) (S (PP (IN as) (PP (IN with) (NP (DT the) (NN semiconductor) (, ,) (NNS electronics) (, ,) (CC and) (NN automobile) (NNS industries)))) (, ,) (NP (JJ Japanese) (NNS companies)) (VP (MD will) (VP (VB use) (NP (JJ U.S.-developed) (NN technology)) (S (VP (TO to) (VP (VB gain) (NP (NN trade) (NNS advantages))))))))))))))) (. .)))

(S1 (S (NP (NNP Mr.) (NNP Bologna)) (VP (VBD said) (SBAR (S (NP (DT the) (NN sale)) (VP (MD would) (VP (VB allow) (S (NP (NNP Gen-Probe)) (VP (VP (TO to) (VP (VB speed) (PRT (RP up)) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (NN technology)))))) (, ,) (CC and) (VP (TO to) (VP (ADVP (RBR more) (RB quickly)) (VB apply) (NP (NP (VBG existing) (NN technology)) (PP (TO to) (NP (NP (DT an) (NN array)) (PP (IN of) (NP (JJ diagnostic) (NNS products))))) (SBAR (S (NP (DT the) (NN company)) (VP (VBZ wants) (S (VP (TO to) (VP (VB offer))))))))))))))))) (. .)))

(S1 (S (PP (IN By) (NP (NP (CD 1988)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (RB only) (CD 10) (JJ genetic) (JJ probe-based) (NNS tests)) (PP (IN of) (NP (NP (JJ diagnostic) (JJ infectious) (NNS diseases)) (PP (IN of) (NP (NNS humans)))))) (VP (VBD had) (VP (VBN been) (VP (VBN approved) (PP (IN for) (NP (NN marketing))) (PP (IN by) (NP (DT the) (NNP Food) (CC and) (NNP Drug) (NNP Administration)))))))))) (, ,) (NP (NP (CD eight)) (PP (IN of) (NP (PRP them)))) (VP (VBD had) (VP (VBN been) (VP (VBN developed) (CC and) (VBN sold) (PP (IN by) (NP (NNP Gen-Probe)))))) (. .)))

(S1 (S (NP (NP (NNP Osamu) (NNP Nagayama)) (, ,) (NP (NP (NN deputy) (NN president)) (PP (IN of) (NP (NP (NNP Chugai)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ spends) (NP (NP (QP (RB about) (CD 15)) (NN %)) (PP (IN of) (NP (PRP$ its) (NNS sales)))) (PP (IN on) (NP (NN research) (CC and) (NN development))))))))) (, ,)) (VP (VBD was) (ADJP (JJ unable) (S (VP (TO to) (VP (VB pinpoint) (SBAR (WHNP (WHADJP (WRB how) (JJ much)) (NN money)) (S (NP (NNP Chugai)) (VP (MD would) (VP (VB pump) (PP (IN into) (NP (NNP Gen-Probe)))))))))))) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP We)) (VP (VBP think) (SBAR (S (NP (NNP Gen-Probe)) (VP (VBZ has) (ADJP (ADJP (NN technology) (JJ important)) (PP (TO to) (NP (NP (NNS people) (POS 's)) (NN health)))))))) (, ,) ('' ')) ('' ') (NP (PRP he)) (VP (VBD said) (, ,) (S (VP (VBG adding) (: :) (`` `) (S (`` `) (NP (PRP We)) (VP (VBP think) (SBAR (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN for) (S (NP (PRP us)) (VP (TO to) (VP (VB have) (NP (JJ such) (NN technology)))))))))))))) (. .) ('' ') ('' ')))

(S1 (S (NP (NP (PRP He)) (CC and) (NP (NNP Mr.) (NNP Bologna))) (VP (VBD emphasized) (SBAR (IN that) (S (NP (DT both) (NNS companies)) (VP (MD would) (VP (VB gain) (NP (JJ technological) (NN knowledge)) (PP (IN through) (NP (NP (DT the) (NN sale)) (PP (IN of) (NP (NP (NNP Gen-Probe)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB expand) (`` `) (ADVP (`` `) (RB significantly) ('' ')) ('' ') (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (DT the) (NN acquisition)))))))))))))))))) (. .)))

(S1 (S (PP (IN In) (NP (CD 1988))) (, ,) (NP (NNP Chugai)) (VP (VBD had) (NP (NP (JJ net) (NN income)) (PP (IN of) (NP (QP ($ $) (CD 60) (CD million)))) (PP (IN on) (NP (NP (NN revenue)) (PP (IN of) (NP (QP ($ $) (CD 991) (CD million)))))))) (. .)))

(S1 (S (NP (NNP GenProbe)) (VP (VBD had) (NP (NP (DT a) (JJ net) (NN loss)) (PP (IN of) (NP (QP ($ $) (CD 9.5) (CD million)))) (PP (IN on) (NP (NP (NN revenue)) (PP (IN of) (NP (QP ($ $) (CD 5.8) (CD million)))))))) (. .)))

(S1 (S (ADVP (RB Recently)) (, ,) (NP (NNP Gen-Probe)) (VP (VBD received) (NP (NP (DT a) (JJ broad) (NNP U.S.) (NN patent)) (PP (IN for) (NP (NP (DT a) (NN technology)) (SBAR (WHNP (WDT that)) (S (VP (VBZ helps) (S (VP (VB detect) (, ,) (VB identify) (CC and) (VB quantify) (NP (JJ non-viral) (NNS organisms)) (PP (IN through) (NP (NP (DT the) (VBG targeting)) (PP (IN of) (NP (NP (DT a) (NN form)) (PP (IN of) (NP (NP (JJ genetic) (NN material)) (VP (VBD called) (NP (JJ ribosomal) (NNP RNA)))))))))))))))))) (. .)))

(S1 (S (PP (IN Among) (NP (JJ other) (NNS things))) (, ,) (NP (NNP Mr.) (NNP Bologna)) (VP (VBD said) (SBAR (IN that) (S (NP (DT the) (NN sale)) (VP (MD will) (VP (VB facilitate) (NP (NP (NP (NNP Gen-Probe) (POS 's)) (NN marketing)) (PP (IN of) (NP (NP (NP (DT a) (JJ diagnostic) (NN test)) (PP (IN for) (NP (VBN acquired) (JJ immune) (NN deficiency) (NN syndrome)))) (, ,) (CC or) (NP (NNP AIDS)))))))))) (. .)))

(S1 (S (S (NP (NNP Chugai)) (ADVP (RB also)) (VP (MD will) (VP (VB help) (NP (NNP Gen-Probe)) (PP (IN with) (NP (NP (PRP$ its) (UCP (JJ regulatory) (CC and) (NN marketing)) (NN expertise)) (PP (IN in) (NP (NNP Asia)))))))) (, ,) (NP (NNP Mr.) (NNP Bologna)) (VP (VBD said)) (. .)))

(S1 (S (S (NP (NP (DT The) (NN tender) (NN offer)) (PP (IN for) (NP (NP (NNP Gen-Probe) (POS 's)) (NNS shares)))) (VP (VBZ is) (VP (VBN expected) (S (VP (TO to) (VP (VB begin) (PP (IN next) (NP (NNP Monday))))))))) (, ,) (NP (DT the) (NN company)) (VP (VBD said)) (. .)))

